Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Characterization of an androgen-responsive, ornithine decarboxylase-related protein in mouse kidney.

Silander KM, Pihlajamaa P, Sahu B, Jänne OA, Andersson LC.

Biosci Rep. 2017 Jul 12;37(4). pii: BSR20170163. doi: 10.1042/BSR20170163. Print 2017 Aug 31.

2.

Androgen receptor- and PIAS1-regulated gene programs in molecular apocrine breast cancer cells.

Malinen M, Toropainen S, Jääskeläinen T, Sahu B, Jänne OA, Palvimo JJ.

Mol Cell Endocrinol. 2015 Oct 15;414:91-8. doi: 10.1016/j.mce.2015.07.024. Epub 2015 Jul 26.

PMID:
26219822
3.

Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling.

Pihlajamaa P, Sahu B, Jänne OA.

Endocr Rev. 2015 Aug;36(4):357-84. doi: 10.1210/er.2015-1034. Epub 2015 Jun 8. Review.

PMID:
26052734
4.

Identification of several potential chromatin binding sites of HOXB7 and its downstream target genes in breast cancer.

Heinonen H, Lepikhova T, Sahu B, Pehkonen H, Pihlajamaa P, Louhimo R, Gao P, Wei GH, Hautaniemi S, Jänne OA, Monni O.

Int J Cancer. 2015 Nov 15;137(10):2374-83. doi: 10.1002/ijc.29616. Epub 2015 Jun 17.

5.

SUMO ligase PIAS1 functions as a target gene selective androgen receptor coregulator on prostate cancer cell chromatin.

Toropainen S, Malinen M, Kaikkonen S, Rytinki M, Jääskeläinen T, Sahu B, Jänne OA, Palvimo JJ.

Nucleic Acids Res. 2015 Jan;43(2):848-61. doi: 10.1093/nar/gku1375. Epub 2014 Dec 30.

6.

Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo.

Sahu B, Pihlajamaa P, Dubois V, Kerkhofs S, Claessens F, Jänne OA.

Nucleic Acids Res. 2014 Apr;42(7):4230-40. doi: 10.1093/nar/gkt1401. Epub 2014 Jan 22.

7.

Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs.

Pihlajamaa P, Sahu B, Lyly L, Aittomäki V, Hautaniemi S, Jänne OA.

EMBO J. 2014 Feb 18;33(4):312-26. doi: 10.1002/embj.201385895. Epub 2014 Jan 22.

8.

Genomic region operation kit for flexible processing of deep sequencing data.

Ovaska K, Lyly L, Sahu B, Jänne OA, Hautaniemi S.

IEEE/ACM Trans Comput Biol Bioinform. 2013 Jan-Feb;10(1):200-6. doi: 10.1109/TCBB.2012.170.

PMID:
23702556
9.

SUMO-1 regulates body weight and adipogenesis via PPARγ in male and female mice.

Mikkonen L, Hirvonen J, Jänne OA.

Endocrinology. 2013 Feb;154(2):698-708. doi: 10.1210/en.2012-1846. Epub 2012 Dec 27.

PMID:
23270804
10.

FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells.

Sahu B, Laakso M, Pihlajamaa P, Ovaska K, Sinielnikov I, Hautaniemi S, Jänne OA.

Cancer Res. 2013 Mar 1;73(5):1570-80. doi: 10.1158/0008-5472.CAN-12-2350. Epub 2012 Dec 26.

11.

Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.

Donner KM, Hiltunen TP, Jänne OA, Sane T, Kontula K.

Eur J Endocrinol. 2012 Dec 10;168(1):K9-K18. doi: 10.1530/EJE-12-0532. Print 2013 Jan.

PMID:
23076843
12.

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.

Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T.

Oncogene. 2012 Oct 11;31(41):4460-71. doi: 10.1038/onc.2011.624. Epub 2012 Jan 23.

PMID:
22266859
13.

Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.

Urbanucci A, Marttila S, Jänne OA, Visakorpi T.

Prostate. 2012 Aug 1;72(11):1223-32. doi: 10.1002/pros.22473. Epub 2011 Dec 27.

PMID:
22212979
14.

Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.

Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J, Vesterinen T, Nordling S, Kallioniemi O, Hautaniemi S, Jänne OA.

EMBO J. 2011 Sep 13;30(19):3962-76. doi: 10.1038/emboj.2011.328.

15.

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.

Urbanucci A, Sahu B, Seppälä J, Larjo A, Latonen LM, Waltering KK, Tammela TL, Vessella RL, Lähdesmäki H, Jänne OA, Visakorpi T.

Oncogene. 2012 Apr 26;31(17):2153-63. doi: 10.1038/onc.2011.401. Epub 2011 Sep 12.

PMID:
21909140
16.

The phytoestrogen genistein is a tissue-specific androgen receptor modulator.

Pihlajamaa P, Zhang FP, Saarinen L, Mikkonen L, Hautaniemi S, Jänne OA.

Endocrinology. 2011 Nov;152(11):4395-405. doi: 10.1210/en.2011-0221. Epub 2011 Aug 30.

PMID:
21878517
17.

Intra-articular corticoid injection induces circulating glucocorticoid bioactivity and systemic immune activation in juvenile idiopathic arthritis.

Rintamäki H, Tamm K, Vaarala O, Sidoroff M, Honkanen V, Raivio T, Jänne O, Kolho KL.

Scand J Rheumatol. 2011;40(5):347-53. doi: 10.3109/03009742.2011.560893. Epub 2011 May 30.

PMID:
21619491
18.

Cytoplasmic accumulation of incompletely glycosylated SHBG enhances androgen action in proximal tubule epithelial cells.

Hong EJ, Sahu B, Jänne OA, Hammond GL.

Mol Endocrinol. 2011 Feb;25(2):269-81. doi: 10.1210/me.2010-0483. Epub 2010 Dec 30.

19.

Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei.

Ambrosino C, Tarallo R, Bamundo A, Cuomo D, Franci G, Nassa G, Paris O, Ravo M, Giovane A, Zambrano N, Lepikhova T, Jänne OA, Baumann M, Nyman TA, Cicatiello L, Weisz A.

Mol Cell Proteomics. 2010 Jun;9(6):1352-67. doi: 10.1074/mcp.M900519-MCP200. Epub 2010 Mar 22.

20.

GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.

Venteclef N, Jakobsson T, Ehrlund A, Damdimopoulos A, Mikkonen L, Ellis E, Nilsson LM, Parini P, Jänne OA, Gustafsson JA, Steffensen KR, Treuter E.

Genes Dev. 2010 Feb 15;24(4):381-95. doi: 10.1101/gad.545110.

21.

Androgen receptor and androgen-dependent gene expression in lung.

Mikkonen L, Pihlajamaa P, Sahu B, Zhang FP, Jänne OA.

Mol Cell Endocrinol. 2010 Apr 12;317(1-2):14-24. doi: 10.1016/j.mce.2009.12.022. Epub 2009 Dec 24.

PMID:
20035825
22.

Serum glucocorticoids and adiponectin associate with insulin resistance in children born small for gestational age.

Tenhola S, Todorova B, Jääskeläinen J, Jänne OA, Raivio T, Voutilainen R.

Eur J Endocrinol. 2010 Mar;162(3):551-7. doi: 10.1530/EJE-09-1003. Epub 2009 Dec 17.

PMID:
20019129
23.

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T.

Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6.

24.

Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis.

Turner D, Kolho KL, Mack DR, Raivio T, Leleiko N, Crandall W, Markowitz J, Silverberg MS, Jänne OA, Stempak J, Hyams J, Griffiths AM.

Inflamm Bowel Dis. 2010 Mar;16(3):469-73. doi: 10.1002/ibd.21070.

PMID:
19714760
25.

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Jänne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M.

Cell. 2009 Jul 23;138(2):245-56. doi: 10.1016/j.cell.2009.04.056.

26.

Circulating adiponectin as a marker for glucocorticoid-related side effects in children and adolescents with inflammatory bowel disease.

Vihinen MK, Kolho KL, Jänne OA, Andersson S, Raivio T.

J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):504-6. doi: 10.1097/MPG.0b013e318186c495.

PMID:
19322063
27.

Sumo-1 function is dispensable in normal mouse development.

Zhang FP, Mikkonen L, Toppari J, Palvimo JJ, Thesleff I, Jänne OA.

Mol Cell Biol. 2008 Sep;28(17):5381-90. doi: 10.1128/MCB.00651-08. Epub 2008 Jun 23.

28.

KIT overexpression induces proliferation in astrocytes in an imatinib-responsive manner and associates with proliferation index in gliomas.

Blom T, Fox H, Angers-Loustau A, Peltonen K, Kerosuo L, Wartiovaara K, Linja M, Jänne OA, Kovanen P, Haapasalo H, Nupponen NN.

Int J Cancer. 2008 Aug 15;123(4):793-800. doi: 10.1002/ijc.23576.

29.

Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.

Vihinen MK, Raivio T, Verkasalo M, Jänne OA, Kolho KL.

J Clin Gastroenterol. 2008 Oct;42(9):1017-24. doi: 10.1097/MCG.0b013e3180ca9585.

PMID:
18496232
30.

A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

Wang Q, Li W, Liu XS, Carroll JS, Jänne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M.

Mol Cell. 2007 Aug 3;27(3):380-92.

31.
32.

An adenosine triphosphatase of the sucrose nonfermenting 2 family, androgen receptor-interacting protein 4, is essential for mouse embryonic development and cell proliferation.

Zhang FP, Domanskyi A, Palvimo JJ, Sariola H, Partanen J, Jänne OA.

Mol Endocrinol. 2007 Jun;21(6):1430-42. Epub 2007 Mar 20.

PMID:
17374848
33.

Expression and localization of androgen receptor-interacting protein-4 in the testis.

Domanskyi A, Zhang FP, Nurmio M, Palvimo JJ, Toppari J, Jänne OA.

Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E513-22. Epub 2006 Sep 26.

34.

Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion.

Karvonen U, Jänne OA, Palvimo JJ.

Exp Cell Res. 2006 Oct 1;312(16):3165-83. Epub 2006 Jun 21.

PMID:
16860317
35.

Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription.

Thompson J, Lepikhova T, Teixido-Travesa N, Whitehead MA, Palvimo JJ, Jänne OA.

EMBO J. 2006 Jun 21;25(12):2757-67. Epub 2006 May 25.

36.

Methylprednisolone exposure in pediatric renal transplant patients.

Seikku P, Raivio T, Jänne OA, Neuvonen PJ, Holmberg C.

Am J Transplant. 2006 Jun;6(6):1451-8.

37.

The effects of short-term oral phytoestrogen supplementation on the hypothalamic-pituitary-testicular axis in prostate cancer patients.

Rannikko A, Petas A, Raivio T, Jänne OA, Rannikko S, Adlercreutz H.

Prostate. 2006 Jul 1;66(10):1086-91.

PMID:
16637075
38.

Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia.

Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmüller C, Presul E, Skvortsov S, Crazzolara R, Fiegl M, Raivio T, Jänne OA, Geley S, Meister B, Kofler R.

Blood. 2006 Mar 1;107(5):2061-9. Epub 2005 Nov 17. Erratum in: Blood. 2007 Apr 15;109(8):3234.

PMID:
16293608
39.

Biochemical characterization of androgen receptor-interacting protein 4.

Domanskyi A, Virtanen KT, Palvimo JJ, Jänne OA.

Biochem J. 2006 Feb 1;393(Pt 3):789-95.

40.

Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment.

Hero M, Jänne OA, Näntö-Salonen K, Dunkel L, Raivio T.

J Clin Endocrinol Metab. 2005 Sep;90(9):5141-5. Epub 2005 Jun 28.

PMID:
15985486
41.

Disruption of the murine PIASx gene results in reduced testis weight.

Santti H, Mikkonen L, Anand A, Hirvonen-Santti S, Toppari J, Panhuysen M, Vauti F, Perera M, Corte G, Wurst W, Jänne OA, Palvimo JJ.

J Mol Endocrinol. 2005 Jun;34(3):645-54.

PMID:
15956336
42.

Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception?

Leminen R, Raivio T, Ranta S, Oehler J, von Hertzen H, Jänne OA, Heikinheimo O.

Eur J Endocrinol. 2005 Mar;152(3):411-8.

PMID:
15757858
43.

SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies.

Häkli M, Karvonen U, Jänne OA, Palvimo JJ.

Exp Cell Res. 2005 Mar 10;304(1):224-33. Epub 2004 Nov 23.

PMID:
15707587
44.

Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

Kang Z, Jänne OA, Palvimo JJ.

Mol Endocrinol. 2004 Nov;18(11):2633-48. Epub 2004 Aug 12.

PMID:
15308689
45.

Circulating glucocorticoid bioactivity in the preterm newborn after antenatal betamethasone treatment.

Kajantie E, Raivio T, Jänne OA, Hovi P, Dunkel L, Andersson S.

J Clin Endocrinol Metab. 2004 Aug;89(8):3999-4003.

PMID:
15292340
46.

Serum androgen bioactivity in adolescence: a longitudinal study of boys with constitutional delay of puberty.

Raivio T, Dunkel L, Wickman S, Jänne OA.

J Clin Endocrinol Metab. 2004 Mar;89(3):1188-92.

PMID:
15001607
47.

Small nuclear RING finger protein stimulates the rat luteinizing hormone-beta promoter by interacting with Sp1 and steroidogenic factor-1 and protects from androgen suppression.

Curtin D, Ferris HA, Häkli M, Gibson M, Jänne OA, Palvimo JJ, Shupnik MA.

Mol Endocrinol. 2004 May;18(5):1263-76. Epub 2004 Feb 26.

PMID:
14988433
48.

Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity.

Häkli M, Lorick KL, Weissman AM, Jänne OA, Palvimo JJ.

FEBS Lett. 2004 Feb 27;560(1-3):56-62.

49.

Expression of androgen receptor coregulators in prostate cancer.

Linja MJ, Porkka KP, Kang Z, Savinainen KJ, Jänne OA, Tammela TL, Vessella RL, Palvimo JJ, Visakorpi T.

Clin Cancer Res. 2004 Feb 1;10(3):1032-40.

50.

Small nuclear RING finger protein expression during gonad development: regulation by gonadotropins and estrogen in the postnatal ovary.

Hirvonen-Santti SJ, Sriraman V, Anttonen M, Savolainen S, Palvimo JJ, Heikinheimo M, Richards JS, Jänne OA.

Endocrinology. 2004 May;145(5):2433-44. Epub 2004 Jan 28.

PMID:
14749358

Supplemental Content

Loading ...
Support Center